Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, Hanzeplein 1, PO Box 30.001, Groningen 9700 RB, The Netherlands.
Heart Fail Clin. 2013 Oct;9(4):397-406, vii. doi: 10.1016/j.hfc.2013.07.004. Epub 2013 Aug 19.
In the last few years, there has been a major shift in the treatment of atrial fibrillation (AF) in the setting of hear failure (HF), from rhythm to ventricular rate control in most patients with both conditions. In this article, the authors focus on ventricular rate control and discuss the indications; the optimal ventricular rate-control target, including detailed results of the Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison Between Lenient versus Strict Rate Control II (RACE II) study; and the pharmacologic and nonpharmacologic options to control the ventricular rate during AF in the setting of HF.
在过去的几年中，心力衰竭（HF）合并心房颤动（AF）患者的治疗策略发生了重大转变，大多数此类患者从节律控制转为心室率控制。本文作者重点关注心室率控制，并讨论了适应证、最佳心室率控制目标，包括宽松心室率控制与严格心室率控制比较的永久性 AF 患者心率控制效果试验（RACE II）的详细结果，以及 HF 合并 AF 时控制心室率的药物和非药物选择。
